These data suggest that the effectiveness of 3β‐HSD type 1 as a prognostic marker for is at least equal or higher than other prognostic markers previously reported, which include invasive tumor size, lymph node status, histological grade, PgR status, and HER‐2 status 38, 39. This evidence concerns the gene ERBB2 and neoplasm.